-
Mashup Score: 22What Can 11,000 Proteins In Our Blood Tell Us? - 2 hour(s) ago
The beginnings of a quiet revolution in high-throughput proteomics and A.I.
Source: erictopol.substack.comCategories: General Medicine News, Expert PicksTweet
-
Mashup Score: 1Ai-Med Global Summit 2024 - 2 hour(s) ago
Join us at the AiMed Global Summit 2024, the leading event for artificial intelligence in medicine. Learn from the world’s leading experts, network with your peers, and discover the latest innovations in AI for healthcare. Register today!
Source: aimed.swoogo.comCategories: General Medicine News, Expert PicksTweet
-
Mashup Score: 22What Can 11,000 Proteins In Our Blood Tell Us? - 3 hour(s) ago
The beginnings of a quiet revolution in high-throughput proteomics and A.I.
Source: erictopol.substack.comCategories: General Medicine News, Expert PicksTweet
-
Mashup Score: 72C. Michael Gibson - 18 hour(s) ago
Explore C. Michael Gibson’s 317 photos on Flickr!
Source: www.flickr.comCategories: General Medicine News, Expert PicksTweet
-
Mashup Score: 139Opinion | I’m a Doctor. ChatGPT’s Bedside Manner Is Better Than Mine. (Gift Article) - 23 hour(s) ago
My job is no longer safe.
Source: www.nytimes.comCategories: General Medicine News, Expert PicksTweet
-
Mashup Score: 0Memory Loss Isn’t the Only Sign of Dementia - 1 day(s) ago
Here are five other common red flags to look out for.
Source: www.nytimes.comCategories: General Medicine News, Expert PicksTweet
-
Mashup Score: 387Impact of JN.1 booster vaccination on neutralisation of SARS-CoV-2 variants KP.3.1.1 and XEC - 1 day(s) ago
The SARS-CoV-2 KP.3.1.1 lineage is currently the dominating lineage on several continents. In parallel, the XEC lineage, a recombinant of KS.1.1 and KP.3.3, is on track of becoming the next dominant lineage in Europe and North America. Here we performed a rapid virological characterisation of the XEC lineage and studied the impact of JN.1 mRNA booster vaccination on KP.3.1.1 and XEC neutralisation. ### Competing Interest Statement A.K., I.N., S.P. and M.H. conducted contract research (testing of vaccinee sera for neutralising activity against SARS-CoV-2) for Valneva unrelated to this work. G.M.N.B. served as advisor for Moderna and S.P. served as advisor for BioNTech, unrelated to this work. A.D-J. served as advisor for Pfizer, unrelated to this work. All other authors declare no competing interests.
Source: www.biorxiv.orgCategories: General Medicine News, Expert PicksTweet
-
Mashup Score: 4778
PICOBOO is a randomised, adaptive trial evaluating the immunogenicity, reactogenicity, and safety of COVID-19 booster strategies. We report data for second boosters among individuals 50-<70 years old primed with AZD1222 (50-<70y-AZD1222) until Day 84.
Source: www.journalofinfection.comCategories: General Medicine News, Expert PicksTweet-
From a randomized trial, proof that the @Novavax booster induces less acute side effects and more sustained levels of anti-spike IgG antibodies than mRNA shots @moderna_tx @pfizer https://t.co/dl2TkyyjaU Right panel represents anti-spike IgG unadjusted fold reductions at… https://t.co/S9LOz7ISRQ https://t.co/LfxToMnJVo
-
-
Mashup Score: 82World's first ovarian cancer vaccine being developed in UK 'could wipe out the disease' - 2 day(s) ago
Experts hope the ovarian cancer jab could work in a similar way to the human papillomavirus (HPV) vaccine, which is on track to stamp out cervical cancer.
Source: news.sky.comCategories: General Medicine News, Expert PicksTweet
-
Mashup Score: 1451
Nature – The treatment’s success in three people raises hopes for mass production of cutting-edge CAR T therapies.
Source: www.nature.comCategories: General Medicine News, Expert PicksTweet
Two proteomic studies have found peaks of plasma proteins at different ages, which suggests that the aging process is non-linear Links and details https://t.co/J8wio9Sqgm https://t.co/NGkVO98odB